#United Kingdom

A new analysis finds that Gilead Sciences’ updated version of its key antiretroviral tenofovir may not actually offer any safety benefits.

U.K. public health officials have expressed great concern over this latest sign of evolution of the sexually transmitted infection.

After a gay man tested HIV positive, a test of his hair indicated he’d adhered well to PrEP—but did he contract a drug-resistant strain?

Worldwide, kidneys from three deceased HIV-positive donors have been transplanted into six people living with the virus.

The controversial head of the AIDS Healthcare Foundation has taken his PrEP-skepticism campaign to the prestigious medical journal AIDS.

This is the first decline in the rate since the mid-1990s, with a major London sexual health clinic charting an 80 percent drop since 2015.

A recent analysis helped shed light on the stillborn rate among those living in wealthier nations.

In a British study, men on PrEP also reported many psychosocial benefits to using Truvada for prevention.

The distribution of contaminated blood products left nearly 7,500 people infected with HIV and hepatitis C in the 1970s and ’80s.

The science behind Truvada as pre-exposure prophylaxis reveals an awesome tool that is apparently already helping shrink U.S. HIV rates.

The risk is particularly high the first year after receiving an HIV diagnosis.

Critics of the devices argue neither virus can be transmitted via spitting and that such suggestions reinforce stigma and misperceptions.

British press publishes false information about HIV cure.

“I want to make my mom proud,” he says of Princess Diana in a new documentary.

The U.K.-based group provides HIV information, notably through the website aidsmap.com.

Truvada as pre-exposure prophylaxis (PrEP), unapproved in the United Kingdom, could dramatically reduce new infections among gay men there.